Registration is now open for the Encuentros 2025 conference – CRISPR, Advanced Cell Models, and beyond: Navigating the Future of Therapeutic Discovery

Granada, January 15, 2025

We are thrilled to announce that registration for Encuentros 2025 is officially open! Join us on February 21, 2025, for an event dedicated to exploring the forefront of CRISPR, Advanced Cell Models, and the Future of Therapeutic Discovery.

This is a unique opportunity to engage with leading experts and delve into the latest advancements in gene editing, cellular models, and AI-driven drug discovery. Our program includes an interactive roundtable discussion on new academic compound libraries and the impact of innovative cell model technologies on early drug discovery.
We will have the participation of renowned international experts, including some members of the Andalusian Biomodels platform and representatives from LA3 - Drug Screening and Drug-Target Interaction Analysis Platform, who will share their valuable experience and knowledge.

Come and join us in person in the beautiful city of Granada or online. The deadline for registration is February 10.
You can find more information and register here.

Next, you can check the confirmed speakers for this event:

  • Felipe Cortés, Centro Nacional de Investigaciones Oncológicas (CNIO) - Using CRISPR to understand DNA double-strand break repair
  • Miguel Ángel Moreno Mateos, Centro Andaluz de Biología del Desarrollo (CABD) - RNA-targeting CRISPR-Cas optimizations and screenings to understand early development of vertebrates
  • Troy Luster - CRISPR screens for the discovery of immune enhancing edits
  • Sandra Rodríguez Perales, Centro Nacional de Investigaciones Oncológicas (CNIO) - Combination of CRISPR genome editing and cytogenetic technologies to create models that mimic chromosomal and genetic alterations found in cancer
  • Francisco Martín Molina, Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) - Engineering lymphocytes with genome editing
  • María Jesús Vicent, Centro de Investigación Príncipe Felipe (CIPF) - Unveiling Tropism and Biological Barrier Crossing Capabilities with Polypeptide-based Therapeutics
  • Juan Antonio Marchal, Universidad de Granada (UGR) - Biofabrication of advanced in vitro preclinical 3D models and personalized systems for transforming cancer therapy
  • Rosario Fernández Godino, Fundación MEDINA – M3dinAI DrugQuest: Advancing Cancer Drug Discovery with AI-Enhanced 3D Screening
  • Jordi Mestres, Chemotargets - Protein-directed Generative Drug Design
  • Guillermo Rodríguez Lázaro, AIA - Molecular AI: overcoming the challenge of heterogeneous data

 

We look forward to your participation and to making this event a great success together!